Cuba’s Cimavax, Lung Cancer Vaccine Is Heading to U.S.
The world's first lung cancer vaccine called as Cimavax was launched back in 2011 by Cuba. Cuban government made the vaccine free for public. Today, other countries want to try out the same. With improved relations of U.S. with Cuba, USA researchers will soon have access to this lung cancer vaccine. Here is what you need to know about this lung cancer vaccine: Cimavax is a vaccine treatment for non small cell lung cancer. It targets a protein called epidermal growth factor (EGF) and it works by stimulating the immune response to make antibodies that bind to EGF. This stops the EGF to receptors on cancer cells and slows the growth of cancer. As the vaccine initiates an immune response against EGF protein, it depletes a vital thing that cancer needs to grow and survive. Thus, the cancer cannot grow anymore. When vaccinated, EGF, among other compounds, enters the bloodstream and encourages the immune system to produce antibodies that suppress the effects of EGF. The vaccine is given to